Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Reliefacyn Plus
- Development stage
- Unknown
- Lead developer
- Sonoma Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Reliefacyn Plus is a prescription-strength topical formulation developed for the management of various dermatological conditions, including atopic dermatitis, radiation dermatitis, and post-procedure skin care. The product is based on Sonoma Pharmaceuticals' proprietary Microcyn technology, which utilizes a stabilized hypochlorous acid (HOCl) solution. Hypochlorous acid is a naturally occurring molecule produced by human white blood cells as part of the innate immune response to combat pathogens and promote healing. Reliefacyn Plus acts as a skin and wound cleanser that helps to reduce inflammation, alleviate pruritus (itching), and provide a moist environment conducive to the healing of damaged skin. It is typically formulated as a hydrogel or liquid and is cleared by the FDA as a medical device for the management of skin integrity and wound care.
- Brand names
- Reliefacyn Plus
- Other names
- Reliefacyn
Beyond the preview
Go deeper on Reliefacyn Plus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Reliefacyn Plus.